secwatch.observer — SEC 8-K summary
======================================

Issuer:     PHIBRO ANIMAL HEALTH CORP (PAHC)
CIK:        0001069899
Form:       8-K
Filed at:   2023-11-08T23:59:59+00:00
Accession:  0001558370-23-018296
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phibro Animal Health reports Q1 net loss of $8.0M; lowers FY2024 guidance
-------------------------------------------------------------------------

- Net sales $231.3M (-1% YoY); net loss $8.0M vs $3.9M net income prior year; diluted loss per share $0.20.
- Adjusted EBITDA $18.7M (-16% YoY); adjusted diluted EPS $0.14 (-33%).
- Animal Health segment sales up 4% to $160.5M; Mineral Nutrition down 6%; Performance Products down 18%.
- FY2024 guidance reduced: net sales $980M-$1.02B, adjusted EBITDA $106M-$112M, adjusted diluted EPS $1.04-$1.16.
- Results include $10.4M pension settlement charge, $6.7M FX losses; Israel conflict causing manufacturing disruptions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069899/000155837023018296/0001558370-23-018296-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069899/000155837023018296/pahc-20231108x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-018296

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer